@article{42b4ec6d6c88474d987c74ba27dfaf5d,
title = "Future relevance of CSF biomarkers in modern MS treatment",
keywords = "RELAPSING MULTIPLE-SCLEROSIS, PLACEBO-CONTROLLED TRIAL, CEREBROSPINAL-FLUID, OLIGOCLONAL BANDS, ORAL FINGOLIMOD, NATALIZUMAB TREATMENT, FTY720 FINGOLIMOD, IMMUNE, INTERFERON, DIAGNOSIS",
author = "Georg Pilz and Peter Wipfler and Andrea Harrer and Barbara Holl and Katrin Oppermann and Stefan Golaszewski and Eugen Trinka and J{\"o}rg Kraus",
note = "alle: Universit{\"a}tsklinik f{\"u}r Neurologie, Paracelsus Medizinische Privatuniversit{\"a}t, Christian-Doppler-Klinik/SALK",
year = "2012",
doi = "10.1515/labmed-2012-0017",
language = "Deutsch",
volume = "36",
pages = "383--388",
journal = "LaboratoriumsMedizin-Journal of Laboratory Medicine",
issn = "0342-3026",
number = "6",
}